FDA To Inspect Industry's Electronic Record Keeping Systems
Pharma companies may have more to worry about than potential GMP violations when FDA inspectors show up at their door. The agency recently announced that it would begin conducting inspections to determine if industry is in compliance with the regulation governing electronic records and electronic signatures
You may also be interested in...
Regulation of systems for electronic record keeping and electronic signatures can be achieved through existing law and predicate rules, the Industry Coalition on Part 11 asserts in citizen's petition.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials